出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2022年11月
ラテンアメリカのフローサイトメトリー市場 : 技術 (細胞ベース、ビーズベース)、製品とサービス (分析装置、ソーター、消耗品、ソフトウェア)、用途 ［研究、(臨床-がん、血液学)、産業］、エンドユーザー (バイオテクノロジー、病院) – 2027 年までの予測
Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) – Forecast to 2027
| ページ数 | 202 |
| 図表数 | 189 |
| 種別 | 英文調査報告書 |
| 価格 |
The Latin American flow cytometry market is estimated to register a CAGR of 7.1% to reach USD 379 million by 2027 from USD 269 million in 2022. The growing prevalence of cancer and HIV/ AIDS, growing research activities which adopt flow cytometry techniques, and an increase in the innovation efforts to develop technologically advanced instruments and software are prominently driving the growth of the Latin American Flow cytometry market. However, the high cost of flow cytometry products such as instruments and consumables, is a major factor that is expected to restrain market growth to a certain extent.
“The reagents and consumables subsegment accounted for the highest growth rate in the Latin American Flow Cytometry market, by product & service, during the forecast period”
In 2021, the reagents and consumables subsegment accounted for the highest growth rate. Factors such as continuous demand for flow cytometry reagents for diagnostic applications and growing research activities that use flow cytometry techniques are expected to favor the growth of this market.
“Mexico: The fastest-growing country in the Latin American Flow cytometry market”
The Mexican market is estimated to record the highest CAGR during the forecast period. Favorable trade agreements to support the availability of flow cytometry products in the country and the growth of the pharmaceutical industry are expected to support market growth in the country.
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 50% and Demand Side 50%
• By Designation: C-level (Managers) – 45%, D-level (CXOs, Directors)- 30%, and Others (Executives) – 25%
• By Region- Latin America: Brazil -20%, Mexico -20%, Argentina -20%, Colombia -20%, Chile- 15%, Rest of Latin America- 5%
List of Companies Profiled in the Report:
• Becton, Dickinson and Company (US)
• Danaher Corporation (US)
• Thermo Fisher Scientific, Inc. (US)
• Agilent Technologies, Inc. (US)
• Sony Group Corporation (Japan)
• Bio-Rad Laboratories, Inc. (US)
• Miltenyi Biotec GmbH (Germany)
• Enzo Biochem, Inc. (US)
• Sysmex Corporation (Japan)
• Luminex Corporation (US)
• bioMérieux S.A. (France)
• Sartorius AG (Germany)
• Union Biometrica, Inc. (US)
• Takara Bio, Inc. (Japan)
• Cytek Biosciences, Inc. (US)
• Apogee Flow Systems Ltd. (UK)
• BioLegend, Inc. (US)
Research Coverage:
This report provides a detailed picture of the Latin American Flow Cytometry Market. It aims at estimating the size and future growth potential of the market across different segments such as product & service, technology, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall Latin American Flow Cytometry Market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, challenges, restraints, trends, and opportunities
目次
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.3 STUDY SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 YEARS CONSIDERED 30
1.4 CURRENCY CONSIDERED 30
1.5 LIMITATIONS 30
1.6 STAKEHOLDERS 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY DATA 33
2.1.2 PRIMARY DATA 34
FIGURE 2 LATIN AMERICAN FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES 34
2.2 MARKET ESTIMATION METHODOLOGY 35
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 35
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 36
FIGURE 4 MARKET SIZE ESTIMATION (2021) 36
2.3 DATA TRIANGULATION APPROACH 38
FIGURE 5 DATA TRIANGULATION METHODOLOGY 38
2.4 CAGR PROJECTIONS 39
2.4.1 SUPPLY-SIDE ANALYSIS 39
2.4.2 DEMAND-SIDE ANALYSIS 39
2.5 INSIGHTS FROM PRIMARY EXPERTS 40
3 EXECUTIVE SUMMARY 41
FIGURE 6 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 41
FIGURE 7 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION) 42
FIGURE 8 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 42
FIGURE 9 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 43
4 PREMIUM INSIGHTS 44
4.1 LATIN AMERICAN FLOW CYTOMETRY MARKET OVERVIEW 44
FIGURE 10 ADVANCEMENTS IN FLOW CYTOMETRY TECHNIQUES TO DRIVE MARKET GROWTH 44
4.2 LATIN AMERICAN FLOW CYTOMETRY MARKET SHARE, BY PRODUCT & SERVICE (2021) 45
FIGURE 11 REAGENTS AND CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2021 45
4.3 LATIN AMERICAN FLOW CYTOMETRY MARKET SHARE, BY TECHNOLOGY, 2022 VS. 2027 46
FIGURE 12 CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 46
4.4 LATIN AMERICAN FLOW CYTOMETRY MARKET SHARE, BY END USER, 2022 46
FIGURE 13 ACADEMIC AND RESEARCH INSTITUTES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
FIGURE 14 LATIN AMERICAN FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
5.2.1 DRIVERS 48
5.2.1.1 Increasing incidence of cancer and HIV/AIDS 48
TABLE 1 LATIN AMERICA: CANCER INCIDENCE, BY COUNTRY, 2020 48
TABLE 2 LATIN AMERICA: INCIDENCE OF HIV/AIDS, BY COUNTRY, 2021 48
5.2.1.2 Research activities such as drug discovery using flow cytometry techniques 49
5.2.1.3 Use of flow cytometry in regenerative medicine 50
5.2.1.4 Technological advancements such as multicolor fluorescence, compact design, and automation in flow cytometry instruments 50
TABLE 3 IMPORTANT TECHNOLOGICAL ADVANCEMENTS (2019–2022) 50
5.2.2 RESTRAINTS 52
5.2.2.1 High cost of instruments and consumables 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Adoption of recombinant DNA technology for antibody production 52
5.2.3.2 International collaborations in biotechnology 53
5.2.4 CHALLENGES 53
5.2.4.1 Shortage of well-trained and skilled professionals 53
5.3 SUPPLY CHAIN ANALYSIS 53
FIGURE 15 SUPPLY CHAIN OF FLOW CYTOMETRY PRODUCTS & SERVICES 54
5.3.1 KEY INFLUENCERS 55
5.4 VALUE CHAIN ANALYSIS 55
FIGURE 16 LATIN AMERICAN FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS 55
5.5 ECOSYSTEM ANALYSIS 56
FIGURE 17 FLOW CYTOMETRY MARKET: ECOSYSTEM ANALYSIS 56
5.5.1 ROLE IN ECOSYSTEM 56
5.6 REGULATORY ANALYSIS 57
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 57
TABLE 4 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 57
5.7 PORTER’S FIVE FORCES ANALYSIS 58
TABLE 5 FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS 58
5.7.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 58
5.7.2 BARGAINING POWER OF SUPPLIERS 58
5.7.3 BARGAINING POWER OF BUYERS 58
5.7.4 THREAT OF SUBSTITUTES 59
5.7.5 THREAT OF NEW ENTRANTS 59
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 60
FIGURE 18 REVENUE SHIFT AND NEW REVENUE POCKETS FOR FLOW CYTOMETRY MARKET 60
5.9 KEY CONFERENCES AND EVENTS IN 2022–2023 60
TABLE 6 FLOW CYTOMETRY MARKET: DETAILED LIST OF RELEVANT EVENTS AND CONFERENCES 60
5.10 TRADE DATA 61
TABLE 7 IMPORT DATA FOR FLOW CYTOMETRY INSTRUMENTS, BY COUNTRY, 2017–2021 (USD THOUSAND) 61
TABLE 8 EXPORT DATA FOR FLOW CYTOMETRY INSTRUMENTS, BY COUNTRY,
2017–2021 (USD THOUSAND) 61
5.11 PRICING ANALYSIS 62
TABLE 9 GLOBAL AVERAGE COST OF FLOW CYTOMETERS, BY TYPE 62
TABLE 10 GLOBAL AVERAGE COST OF FLOW CYTOMETERS AND OTHER PRODUCTS,
BY COMPANY 62
TABLE 11 IMPORT SHIPMENT DATA OF FLOW CYTOMETERS IN BRAZIL (2021) 62
5.11.1 COST OF FLOW CYTOMETRY SOFTWARE 63
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 63
FIGURE 19 KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND THEIR INFLUENCE ON BUYING PROCESS 63
FIGURE 20 KEY BUYING CRITERIA FOR FLOW CYTOMETRY
PRODUCTS AMONG END USERS 63
6 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE 64
6.1 INTRODUCTION 65
TABLE 12 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 65
6.2 REAGENTS AND CONSUMABLES 65
6.2.1 GROWING R&D TO DRIVE MARKET GROWTH 65
TABLE 13 LATIN AMERICAN FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 66
6.3 INSTRUMENTS 66
TABLE 14 LATIN AMERICAN FLOW CYTOMETRY INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 67
TABLE 15 LATIN AMERICAN FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 67
6.3.1 CELL ANALYZERS 67
TABLE 16 LATIN AMERICAN FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 68
TABLE 17 LATIN AMERICAN FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY PRICE RANGE, 2020–2027 (USD MILLION) 68
6.3.1.1 High-range cell analyzers 69
6.3.1.1.1 Adoption of high-range cell analyzers among end users in larger economies to drive growth 69
TABLE 18 LATIN AMERICAN HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 69
6.3.1.2 Mid-range cell analyzers 69
6.3.1.2.1 Availability of compact and high-performance analyzers to support growth 69
TABLE 19 LATIN AMERICAN MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 70
6.3.1.3 Low-range cell analyzers 70
6.3.1.3.1 Low-range analyzers widely adopted among price-sensitive end users 70
TABLE 20 LATIN AMERICAN LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 70
6.3.2 CELL SORTERS 71
TABLE 21 LATIN AMERICAN FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 71
TABLE 22 LATIN AMERICAN FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY PRICE RANGE, 2020–2027 (USD MILLION) 72
6.3.2.1 High-range cell sorters 72
6.3.2.1.1 High cost and budgetary limitations to restrain growth 72
TABLE 23 LATIN AMERICAN HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 72
6.3.2.2 Mid-range cell sorters 73
6.3.2.2.1 Cost-efficiency and frequent product launches for mid-range sorters to drive growth 73
TABLE 24 LATIN AMERICAN MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 73
6.3.2.3 Low-range cell sorters 73
6.3.2.3.1 Research facilities and small-scale diagnostic labs to be major end users of low-range sorters 73
TABLE 25 LATIN AMERICAN LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
6.4 SERVICES 74
6.4.1 FLOW CYTOMETRY SERVICES ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE 74
TABLE 26 LATIN AMERICAN FLOW CYTOMETRY SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 75
6.5 SOFTWARE 75
6.5.1 TECHNOLOGICAL ADVANCEMENTS IN SOFTWARE TO DRIVE MARKET GROWTH 75
TABLE 27 LATIN AMERICAN FLOW CYTOMETRY SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 76
6.6 ACCESSORIES 76
6.6.1 PROCEDURAL BENEFITS OFFERED BY FLOW CYTOMETRY ACCESSORIES TO SUPPORT MARKET GROWTH 76
TABLE 28 LATIN AMERICAN FLOW CYTOMETRY ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 76
7 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY TECHNOLOGY 77
7.1 INTRODUCTION 78
TABLE 29 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 78
7.2 CELL-BASED FLOW CYTOMETRY 78
7.2.1 GROWING TECHNOLOGICAL ADVANCEMENTS IN CELL-BASED ASSAYS TO DRIVE GROWTH 78
TABLE 30 LATIN AMERICAN CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 79
7.3 BEAD-BASED FLOW CYTOMETRY 79
7.3.1 HIGH RELIABILITY AND MEASUREMENT CONSISTENCY TO SUPPORT GROWTH 79
TABLE 31 LATIN AMERICAN BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
8 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY END USER 81
8.1 INTRODUCTION 82
TABLE 32 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 82
8.2 ACADEMIC AND RESEARCH INSTITUTES 82
8.2.1 INCREASING RESEARCH ACTIVITIES EXPECTED TO DRIVE GROWTH 82
TABLE 33 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 83
8.3 HOSPITALS AND CLINICAL TESTING LABORATORIES 83
8.3.1 USE OF FLOW CYTOMETRY TECHNIQUES IN CANCER DIAGNOSTICS TO DRIVE MARKET GROWTH 83
TABLE 34 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 84
8.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 84
8.4.1 INCREASING INVESTMENTS IN DRUG DISCOVERY AND DEVELOPMENT TO SUPPORT MARKET GROWTH 84
TABLE 35 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 85
9 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY APPLICATION 86
9.1 INTRODUCTION 87
TABLE 36 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87
9.2 RESEARCH APPLICATIONS 87
TABLE 37 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 88
TABLE 38 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
9.2.1 PHARMACEUTICAL AND BIOTECHNOLOGY 88
TABLE 39 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 89
TABLE 40 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 89
9.2.1.1 Drug discovery 89
9.2.1.1.1 Growing use of flow cytometry instruments in drug discovery cycle to support growth 89
TABLE 41 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2020–2027 (USD MILLION) 90
9.2.1.2 Stem cell research 90
9.2.1.2.1 Increasing focus on stem cell research to drive demand for flow cytometry products 90
TABLE 42 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 91
9.2.1.3 In vitro toxicity testing 91
9.2.1.3.1 Growing adoption of flow cytometry in drug discovery and development to support growth 91
TABLE 43 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
9.2.2 IMMUNOLOGY 92
9.2.2.1 Growing prevalence of infectious and autoimmune diseases to support growth 92
TABLE 44 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 93
9.2.3 CELL SORTING 93
9.2.3.1 Technologically advanced cell sorters to drive market growth 93
TABLE 45 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR CELL SORTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
9.2.4 APOPTOSIS 94
9.2.4.1 Growing use of apoptosis assays to support growth 94
TABLE 46 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 94
9.2.5 CELL CYCLE ANALYSIS 95
9.2.5.1 Use of flow cytometry to detect chromosomal abnormalities to drive growth 95
TABLE 47 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2020–2027 (USD MILLION) 95
9.2.6 CELL VIABILITY 95
9.2.6.1 Growing use of cell viability assays in research to drive growth 95
TABLE 48 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY COUNTRY, 2020–2027 (USD MILLION) 96
9.2.7 CELL COUNTING 96
9.2.7.1 Flow cytometry permits easy differentiation of cells via scattering or staining 96
TABLE 49 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY COUNTRY, 2020–2027 (USD MILLION) 97
9.2.8 OTHER RESEARCH APPLICATIONS 97
TABLE 50 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
9.3 CLINICAL APPLICATIONS 98
TABLE 51 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 52 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
9.3.1 CANCER 99
9.3.1.1 Growing use of flow cytometry techniques in cancer prediction to drive growth 99
TABLE 53 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 99
9.3.2 HEMATOLOGY 100
9.3.2.1 Increasing use of flow cytometry in hematology applications to drive growth 100
TABLE 54 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 100
9.3.3 AUTOIMMUNE DISEASES 100
9.3.3.1 Adoption of flow cytometry for autoimmune disease diagnostics to drive growth 100
TABLE 55 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 101
9.3.4 ORGAN AND TISSUE TRANSPLANTATION 101
9.3.4.1 Growing demand for organ transplants to drive market growth 101
TABLE 56 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR ORGAN TRANSPLANTATION, BY COUNTRY, 2020–2027 (USD MILLION) 102
9.3.5 OTHER CLINICAL APPLICATIONS 102
TABLE 57 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 102
9.4 INDUSTRIAL APPLICATIONS 103
9.4.1 ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN FOOD AND DAIRY INDUSTRIES TO DRIVE GROWTH 103
TABLE 58 LATIN AMERICAN FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 103
10 LATIN AMERICAN FLOW CYTOMETRY MARKET, BY COUNTRY 104
10.1 INTRODUCTION 105
TABLE 59 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 105
TABLE 60 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 105
TABLE 61 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 106
TABLE 62 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 106
TABLE 63 LATIN AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 106
TABLE 64 LATIN AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 65 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107
TABLE 66 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 67 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 68 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 69 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 108
10.2 BRAZIL 109
10.2.1 WELL-ESTABLISHED PRESENCE OF KEY MARKET PLAYERS ENSURING ADOPTION OF FLOW CYTOMETRY PRODUCTS 109
TABLE 70 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 109
TABLE 71 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 109
TABLE 72 BRAZIL: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 73 BRAZIL: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 74 BRAZIL: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 75 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 111
TABLE 76 BRAZIL: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 77 BRAZIL: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 78 BRAZIL: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 79 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 112
10.3 MEXICO 112
10.3.1 FAVORABLE TRADE AGREEMENTS TO SUPPORT AVAILABILITY OF FLOW CYTOMETRY PRODUCTS 112
TABLE 80 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 113
TABLE 81 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 113
TABLE 82 MEXICO: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 83 MEXICO: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 84 MEXICO: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 85 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115
TABLE 86 MEXICO: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 87 MEXICO: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 88 MEXICO: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 89 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 116
10.4 ARGENTINA 116
10.4.1 GROWING RESEARCH INITIATIVES TO SUPPORT MARKET GROWTH 116
TABLE 90 ARGENTINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 117
TABLE 91 ARGENTINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 117
TABLE 92 ARGENTINA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 93 ARGENTINA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 94 ARGENTINA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 95 ARGENTINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 118
TABLE 96 ARGENTINA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 97 ARGENTINA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 98 ARGENTINA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 99 ARGENTINA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 120
10.5 COLOMBIA 120
10.5.1 GROWING RESEARCH ACTIVITIES IN ONCOLOGY AND ORGAN TRANSPLANTATION TO SUPPORT MARKET GROWTH 120
TABLE 100 COLOMBIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 121
TABLE 101 COLOMBIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 121
TABLE 102 COLOMBIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 103 COLOMBIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 104 COLOMBIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 105 COLOMBIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 122
TABLE 106 COLOMBIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 107 COLOMBIA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 108 COLOMBIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 109 COLOMBIA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 124
10.6 CHILE 124
10.6.1 GROWING AWARENESS THROUGH CONFERENCES TO DRIVE MARKET GROWTH 124
TABLE 110 CHILE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 125
TABLE 111 CHILE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 125
TABLE 112 CHILE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 113 CHILE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 114 CHILE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 115 CHILE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 126
TABLE 116 CHILE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 117 CHILE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 118 CHILE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 119 CHILE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 128
10.7 REST OF LATIN AMERICA 128
TABLE 120 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 129
TABLE 121 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 129
TABLE 122 REST OF LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 123 REST OF LATIN AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 124 REST OF LATIN AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 125 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130
TABLE 126 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 127 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 128 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 129 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 132
11 COMPETITIVE LANDSCAPE 133
11.1 INTRODUCTION 133
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 133
TABLE 130 LATIN AMERICAN FLOW CYTOMETRY MARKET: STRATEGIES ADOPTED 133
11.3 REVENUE ANALYSIS 134
FIGURE 21 REVENUE ANALYSIS FOR KEY COMPANIES (2019–2021) 134
11.4 MARKET SHARE ANALYSIS 135
FIGURE 22 LATIN AMERICAN FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 135
TABLE 131 LATIN AMERICAN FLOW CYTOMETRY MARKET: DEGREE OF COMPETITION 135
11.5 LIST OF KEY PLAYERS 136
TABLE 132 DEMAND-SIDE PLAYERS 137
TABLE 133 SUPPLY-SIDE PLAYERS 138
11.6 COMPANY EVALUATION MATRIX 138
11.6.1 STARS 139
11.6.2 EMERGING LEADERS 139
11.6.3 PERVASIVE PLAYERS 139
11.6.4 PARTICIPANTS 139
FIGURE 23 FLOW CYTOMETRY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 140
11.7 COMPETITIVE BENCHMARKING 141
TABLE 134 PRODUCT & SERVICE FOOTPRINT OF COMPANIES 141
11.8 COMPETITIVE SCENARIO AND TRENDS 142
TABLE 135 PRODUCT LAUNCHES AND ENHANCEMENTS
(JANUARY 2019–OCTOBER 2022) 142
TABLE 136 DEALS (JANUARY 2019–OCTOBER 2022) 143
12 COMPANY PROFILES 144
12.1 KEY PLAYERS 144
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 BD (BECTON, DICKINSON AND COMPANY) 144
TABLE 137 BD: BUSINESS OVERVIEW 144
FIGURE 24 BD: COMPANY SNAPSHOT (2021) 145
12.1.2 DANAHER CORPORATION 151
TABLE 138 DANAHER CORPORATION: BUSINESS OVERVIEW 151
FIGURE 25 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 152
12.1.3 THERMO FISHER SCIENTIFIC, INC. 157
TABLE 139 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 157
FIGURE 26 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 158
12.1.4 AGILENT TECHNOLOGIES, INC. 162
TABLE 140 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 162
FIGURE 27 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021) 163
12.1.5 SONY BIOTECHNOLOGY INC. (A SUBSIDIARY OF SONY GROUP CORPORATION) 166
TABLE 141 SONY GROUP CORPORATION: BUSINESS OVERVIEW 166
FIGURE 28 SONY GROUP CORPORATION: COMPANY SNAPSHOT (2021) 167
12.1.6 BIO-RAD LABORATORIES INC. 170
TABLE 142 BIO-RAD LABORATORIES INC.: BUSINESS OVERVIEW 170
FIGURE 29 BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT (2021) 171
12.1.7 MILTENYI BIOTEC 174
TABLE 143 MILTENYI BIOTEC: BUSINESS OVERVIEW 174
12.1.8 ENZO BIOCHEM, INC. 177
TABLE 144 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW 177
FIGURE 30 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2021) 178
12.1.9 SYSMEX CORPORATION 180
TABLE 145 SYSMEX CORPORATION: BUSINESS OVERVIEW 180
FIGURE 31 SYSMEX CORPORATION: COMPANY SNAPSHOT (2021) 181
12.1.10 LUMINEX CORPORATION (A DIASORIN COMPANY) 184
TABLE 146 DIASORIN S.P.A.: BUSINESS OVERVIEW 184
FIGURE 32 DIASORIN S.P.A.: COMPANY SNAPSHOT (2021) 185
12.1.11 BIOMÉRIEUX SA 187
TABLE 147 BIOMÉRIEUX SA: BUSINESS OVERVIEW 187
FIGURE 33 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021) 188
12.1.12 SARTORIUS AG 189
TABLE 148 SARTORIUS AG.: BUSINESS OVERVIEW 189
FIGURE 34 SARTORIUS AG: COMPANY SNAPSHOT (2021) 190
12.1.13 UNION BIOMETRICA, INC. 192
TABLE 149 UNION BIOMETRICA, INC.: BUSINESS OVERVIEW 192
12.1.14 TAKARA BIO, INC. 193
TABLE 150 TAKARA BIO, INC.: BUSINESS OVERVIEW 193
FIGURE 35 TAKARA BIO, INC.: COMPANY SNAPSHOT (2021) 194
12.1.15 CYTEK BIOSCIENCES 195
TABLE 151 CYTEK BIOSCIENCES: BUSINESS OVERVIEW 195
FIGURE 36 CYTEK BIOSCIENCES, INC.: COMPANY SNAPSHOT (2021) 195
12.1.16 APOGEE FLOW SYSTEMS LTD. 197
TABLE 152 APOGEE FLOW SYSTEMS LTD.: BUSINESS OVERVIEW 197
12.1.17 BIOLEGEND, INC. (PART OF PERKINELMER) 198
TABLE 153 BIOLEGEND, INC.: BUSINESS OVERVIEW 198
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 199
13.1 DISCUSSION GUIDE 199
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 204
13.3 CUSTOMIZATION OPTIONS 206
13.4 RELATED REPORTS 206
13.5 AUTHOR DETAILS 207